Literature DB >> 16528409

Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation.

Xueliang Du1, Diane Edelstein, Silvana Obici, Ninon Higham, Ming-Hui Zou, Michael Brownlee.   

Abstract

Insulin resistance markedly increases cardiovascular disease risk in people with normal glucose tolerance, even after adjustment for known risk factors such as LDL, triglycerides, HDL, and systolic blood pressure. In this report, we show that increased oxidation of FFAs in aortic endothelial cells without added insulin causes increased production of superoxide by the mitochondrial electron transport chain. FFA-induced overproduction of superoxide activated a variety of proinflammatory signals previously implicated in hyperglycemia-induced vascular damage and inactivated 2 important antiatherogenic enzymes, prostacyclin synthase and eNOS. In 2 nondiabetic rodent models--insulin-resistant, obese Zucker (fa/fa) rats and high-fat diet-induced insulin-resistant mice--inactivation of prostacyclin synthase and eNOS was prevented by inhibition of FFA release from adipose tissue; by inhibition of the rate-limiting enzyme for fatty acid oxidation in mitochondria, carnitine palmitoyltransferase I; and by reduction of superoxide levels. These studies identify what we believe to be a novel mechanism contributing to the accelerated atherogenesis and increased cardiovascular disease risk occurring in people with insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16528409      PMCID: PMC1395482          DOI: 10.1172/JCI23354

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  69 in total

1.  Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.

Authors:  Anthony J G Hanley; Ken Williams; Michael P Stern; Steven M Haffner
Journal:  Diabetes Care       Date:  2002-07       Impact factor: 19.112

2.  Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite.

Authors:  Ming-Hui Zou; Chaomei Shi; Richard A Cohen
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Triglyceride accumulation protects against fatty acid-induced lipotoxicity.

Authors:  Laura L Listenberger; Xianlin Han; Sarah E Lewis; Sylvaine Cases; Robert V Farese; Daniel S Ory; Jean E Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

4.  Regulation of insulin secretion from beta-cell lines derived from transgenic mice insulinomas resembles that of normal beta-cells.

Authors:  R D'Ambra; M Surana; S Efrat; R G Starr; N Fleischer
Journal:  Endocrinology       Date:  1990-06       Impact factor: 4.736

5.  Early events involved in the development of insulin resistance in Zucker fatty rat.

Authors:  R H Liu; M Mizuta; T Kurose; S Matsukura
Journal:  Int J Obes Relat Metab Disord       Date:  2002-03

6.  Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.

Authors:  Masanori Ozaki; Seinosuke Kawashima; Tomoya Yamashita; Tetsuaki Hirase; Masayuki Namiki; Nobutaka Inoue; Ken-ichi Hirata; Hiroyuki Yasui; Hiromu Sakurai; Yuichi Yoshida; Masahiro Masada; Mitsuhiro Yokoyama
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

7.  Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control.

Authors:  Jakob Larsen; Magne Brekke; Leiv Sandvik; Harald Arnesen; Kristian F Hanssen; Knut Dahl-Jorgensen
Journal:  Diabetes       Date:  2002-08       Impact factor: 9.461

8.  Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells.

Authors:  Massimo Federici; Rossella Menghini; Alessandro Mauriello; Marta Letizia Hribal; Francesca Ferrelli; Davide Lauro; Paolo Sbraccia; Luigi Giusto Spagnoli; Giorgio Sesti; Renato Lauro
Journal:  Circulation       Date:  2002-07-23       Impact factor: 29.690

9.  Specific nitration at tyrosine 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase.

Authors:  Patrick Schmidt; Nikolay Youhnovski; Andreas Daiber; Alina Balan; Momo Arsic; Markus Bachschmid; Michael Przybylski; Volker Ullrich
Journal:  J Biol Chem       Date:  2003-01-31       Impact factor: 5.157

10.  Beneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress.

Authors:  Filomena de Nigris; Lilach O Lerman; Sharon Williams Ignarro; Giacomo Sica; Amir Lerman; Wulf Palinski; Louis J Ignarro; Claudio Napoli
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

View more
  119 in total

1.  Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism.

Authors:  Mingxia Gu; Nicholas M Mordwinkin; Nigel G Kooreman; Jaecheol Lee; Haodi Wu; Shijun Hu; Jared M Churko; Sebastian Diecke; Paul W Burridge; Chunjiang He; Frances E Barron; Sang-Ging Ong; Joseph D Gold; Joseph C Wu
Journal:  Eur Heart J       Date:  2014-11-02       Impact factor: 29.983

2.  De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation.

Authors:  Xiaochao Wei; Jochen G Schneider; Sherene M Shenouda; Ada Lee; Dwight A Towler; Manu V Chakravarthy; Joseph A Vita; Clay F Semenkovich
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

3.  FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis.

Authors:  Kyoichiro Tsuchiya; Jun Tanaka; Yu Shuiqing; Carrie L Welch; Ronald A DePinho; Ira Tabas; Alan R Tall; Ira J Goldberg; Domenico Accili
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

Review 4.  Oxidative stress and diabetic complications.

Authors:  Ferdinando Giacco; Michael Brownlee
Journal:  Circ Res       Date:  2010-10-29       Impact factor: 17.367

5.  Nanoformulated copper/zinc superoxide dismutase exerts differential effects on glucose vs lipid homeostasis depending on the diet composition possibly via altered AMPK signaling.

Authors:  Gopalakrishnan Natarajan; Curtis Perriotte-Olson; Fatema Bhinderwala; Robert Powers; Cyrus V Desouza; Geoffrey A Talmon; Jiang Yuhang; Matthew C Zimmerman; Alexander V Kabanov; Viswanathan Saraswathi
Journal:  Transl Res       Date:  2017-08-15       Impact factor: 7.012

6.  Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha.

Authors:  Katherine A Gallagher; Zhao-Jun Liu; Min Xiao; Haiying Chen; Lee J Goldstein; Donald G Buerk; April Nedeau; Stephen R Thom; Omaida C Velazquez
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

7.  Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes.

Authors:  X Du; D Edelstein; M Brownlee
Journal:  Diabetologia       Date:  2008-07-29       Impact factor: 10.122

8.  Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension.

Authors:  Sarah F Knight; Jianghe Yuan; Siddhartha Roy; John D Imig
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11

9.  Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure.

Authors:  Maria D'Apolito; Xueliang Du; Haihong Zong; Alessandra Catucci; Luigi Maiuri; Tiziana Trivisano; Massimo Pettoello-Mantovani; Angelo Campanozzi; Valeria Raia; Jeffrey E Pessin; Michael Brownlee; Ida Giardino
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

10.  Altered arachidonic acid metabolism via COX-1 and COX-2 contributes to the endothelial dysfunction of penile arteries from obese Zucker rats.

Authors:  A Sánchez; C Contreras; N Villalba; P Martínez; A C Martínez; A Bríones; M Salaíces; A García-Sacristán; M Hernández; D Prieto
Journal:  Br J Pharmacol       Date:  2010-01-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.